IL6 and Miyoshi myopathy: Through the upregulation of interleukin (IL)-6 and receptor activator of NFκB ligand (RANKL), BMSC–MM interactions also promote the differentiation and proliferation of osteoclasts which lead to bone resorption and further promote the growth of MM cells [8,9], forming a vicious cycle of bone destruction and MM cell proliferation.